Alembic Pharmaceuticals Q2 FY27 Profit Jumps 81% on Strong US Business
Why the Alembic US business drove Q2 FY27: formulations up 77%, margins up 520 bps and the question of whether the surge can last.
Tag: Indian pharmaceutical industry results
Read More